Pluri Inc News and Resources

Biotechnology company Pluri Inc. has been granted a new U.S. patent. The CEO and President of Pluri, Yaky Yanay, believes that their continued investment in technology, paired with two decades of expertise, enables them to develop the next generation of medical treatments.